Xylem (NYSE:XYL) Price Target Raised to $162.00

Xylem (NYSE:XYL) had its price target upped by Royal Bank of Canada from $157.00 to $162.00 in a research report issued to clients and investors on Friday, Benzinga reports. The brokerage presently has an “outperform” rating on the industrial products company’s stock. Royal Bank of Canada’s price objective points to a potential upside of 18.07% from the company’s previous close.

A number of other research analysts have also commented on the company. Citigroup increased their price objective on Xylem from $126.00 to $139.00 and gave the company a “neutral” rating in a research report on Monday, April 8th. Oppenheimer lifted their target price on shares of Xylem from $142.00 to $147.00 and gave the stock an “outperform” rating in a report on Friday. Mizuho increased their price target on Xylem from $110.00 to $135.00 and gave the company a “neutral” rating in a research note on Friday. Stifel Nicolaus increased their target price on Xylem from $136.00 to $150.00 and gave the company a “buy” rating in a research note on Wednesday, February 7th. Finally, Robert W. Baird upped their price target on Xylem from $151.00 to $155.00 and gave the company an “outperform” rating in a research note on Friday. Five analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. Based on data from MarketBeat, Xylem has an average rating of “Moderate Buy” and an average target price of $140.70.

Xylem Stock Performance

XYL traded up $1.22 on Friday, hitting $137.21. 1,400,873 shares of the stock traded hands, compared to its average volume of 1,187,337. The business has a fifty day moving average price of $128.41 and a two-hundred day moving average price of $114.89. The company has a current ratio of 1.76, a quick ratio of 1.30 and a debt-to-equity ratio of 0.22. Xylem has a 52 week low of $87.59 and a 52 week high of $138.46. The firm has a market capitalization of $33.26 billion, a PE ratio of 50.54, a P/E/G ratio of 2.61 and a beta of 1.08.

Xylem (NYSE:XYL) last posted its quarterly earnings results on Thursday, May 2nd. The industrial products company reported $0.90 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.84 by $0.06. The firm had revenue of $2.03 billion during the quarter, compared to analyst estimates of $2 billion. Xylem had a net margin of 8.27% and a return on equity of 9.65%. The company’s quarterly revenue was up 40.4% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.72 earnings per share. On average, research analysts predict that Xylem will post 4.13 EPS for the current fiscal year.

Insider Buying and Selling at Xylem

In other news, CAO Geri-Michelle Mcshane sold 1,000 shares of the stock in a transaction that occurred on Tuesday, February 20th. The stock was sold at an average price of $122.89, for a total transaction of $122,890.00. Following the transaction, the chief accounting officer now owns 2,935 shares in the company, valued at $360,682.15. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In other news, CAO Geri-Michelle Mcshane sold 1,000 shares of the company’s stock in a transaction on Tuesday, February 20th. The stock was sold at an average price of $122.89, for a total transaction of $122,890.00. Following the completion of the sale, the chief accounting officer now directly owns 2,935 shares in the company, valued at approximately $360,682.15. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, SVP Franz Cerwinka sold 2,408 shares of the firm’s stock in a transaction dated Thursday, February 8th. The shares were sold at an average price of $121.79, for a total transaction of $293,270.32. Following the completion of the transaction, the senior vice president now directly owns 11,750 shares in the company, valued at $1,431,032.50. The disclosure for this sale can be found here. Insiders own 0.27% of the company’s stock.

Hedge Funds Weigh In On Xylem

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. BI Asset Management Fondsmaeglerselskab A S lifted its holdings in Xylem by 36.1% in the first quarter. BI Asset Management Fondsmaeglerselskab A S now owns 37,457 shares of the industrial products company’s stock valued at $4,841,000 after buying an additional 9,928 shares during the period. Central Pacific Bank Trust Division acquired a new position in Xylem during the 1st quarter worth approximately $1,487,000. Whittier Trust Co. of Nevada Inc. raised its position in shares of Xylem by 3.5% during the first quarter. Whittier Trust Co. of Nevada Inc. now owns 2,317 shares of the industrial products company’s stock worth $299,000 after purchasing an additional 79 shares during the period. Whittier Trust Co. increased its stake in Xylem by 3.0% during the 1st quarter. Whittier Trust Co. now owns 10,473 shares of the industrial products company’s stock valued at $1,354,000 after purchasing an additional 302 shares in the last quarter. Finally, Peregrine Asset Advisers Inc. raised its holdings in Xylem by 1,501.1% during the first quarter. Peregrine Asset Advisers Inc. now owns 56,039 shares of the industrial products company’s stock worth $7,242,000 after buying an additional 52,539 shares during the last quarter. 87.96% of the stock is currently owned by institutional investors and hedge funds.

About Xylem

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.